| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153772 | American Heart Journal | 2005 | 4 Pages |
Abstract
Concurrent use of oral vasodilators does not appear to mask a significant response to inhaled NO on the pulmonary vasculature. Therefore, routine discontinuation of pulmonary vasodilators is likely unnecessary before vasodilator testing in patients with pulmonary arterial hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Richard A. MD, Andrew MD, J. Kevin MD, Victor F. MD, Thomas M. MD,